SilverCape Revises Bid to Acquire PetMed Express
SilverCape has updated its acquisition proposal for PetMed Express, signaling renewed dealmaking interest in the online pet pharmacy space.
SilverCape has come back to the table with a revised proposal to acquire PetMed Express, the online pet pharmacy that has struggled to recapture its former glory in an increasingly competitive direct-to-consumer pet health market. The updated bid suggests SilverCape sees unrecognized value in PETS — or at least believes the current share price is cheap enough to make a move worth revisiting.
PetMed Express has faced real headwinds over the past few years. Vet-direct dispensing, Amazon's push into pet medications, and margin compression have all weighed on the stock. A revised proposal — not a first look, but a second swing — tells you SilverCape isn't walking away easily. That kind of persistence either signals conviction or a negotiating tactic to shake loose a better response from the board.
Read more Prediction Markets Raise Insider Trading Red Flags for Wall Street →
For retail traders, the key question is whether management engages seriously this time or continues to resist. A rejected bid can crush momentum fast, but a negotiated deal typically delivers a premium. Watch the spread between any offer price and where PETS is actually trading — that gap is your risk-reward snapshot in real time.
M&A plays in beaten-down consumer names can move quickly once a revised proposal hits the wire. If SilverCape sharpened its pencil on valuation, the board faces real pressure to respond. Shareholders who've sat through the underperformance may not be so patient with another pass.
Continue reading at SeekingAlpha.
